How Bones Remodel Throughout Life

The skeleton holding you upright right now is not the same physical material it was a decade ago, even though its shape and proportions look unchanged. Bone is living, metabolically active tissue that is continuously broken down and rebuilt through a process called bone remodeling, driven by two opposing cell types working in a coordinated local sequence. Research on adult bone turnover estimates that a meaningful fraction of total skeletal mass, on the order of several percent to more than 10%, is replaced every year, with the exact rate varying by bone type and remodeling site (National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH). This article explains the cellular mechanism behind that turnover, the hormonal signals that control it, and why the pace changes across a human lifespan.

What bone remodeling actually is

Bone remodeling is the lifelong, localized process by which old bone tissue is removed and replaced with new bone tissue, distinct from bone modeling, the process that shapes and enlarges bones during childhood growth. Remodeling continues after skeletal growth stops and persists for the rest of life, serving two purposes simultaneously: repairing microscopic damage from mechanical use and supplying the bloodstream with calcium and phosphate on demand.

The process happens inside small, self-contained working groups of cells called basic multicellular units (BMUs), a concept formalized in bone biology research by Harold Frost in the 1960s. At any given moment, thousands of BMUs are active at different, scattered sites across the skeleton, each one independently cycling through the same sequence: resorption of old bone, a brief reversal phase, and formation of new bone. Because these units are staggered rather than synchronized, the skeleton as a whole never stops remodeling, even though any single microscopic site is only active for a period of months.

This matters because it explains something counterintuitive: bone can be simultaneously very old (in un-remodeled regions) and very new (in recently completed BMU sites) within the same physical bone. A cross-section of a single rib or vertebra contains patches of tissue of different ages, layered like tree rings but scattered rather than concentric, reflecting the history of where remodeling units have recently completed their work.

Bone itself is a composite material, not a single substance. It consists of a flexible collagen protein scaffold reinforced with a rigid mineral component, hydroxyapatite, a crystalline form of calcium phosphate. This combination is why healthy bone resists both bending forces and compressive forces. Pure mineral would be brittle like chalk, while pure collagen would be too flexible to bear weight, and remodeling maintains the balance between the two components as tissue turns over.

The cellular mechanism: resorption, reversal, formation

Bone remodeling runs through three sequential phases at each BMU site, each carried out by a different specialized cell population working in strict order.

Resorption comes first. Osteoclasts, large multinucleated cells derived from the same bone marrow monocyte lineage that produces certain white blood cells, attach to the bone surface and form a sealed compartment against it. Inside that sealed space, osteoclasts secrete hydrochloric acid to dissolve the mineral (hydroxyapatite) component and release enzymes, including cathepsin K, to digest the collagen matrix. This resorption phase excavates a small cavity, called a resorption pit or, in the case of long bones, a cutting cone, over a period researchers generally describe as roughly two to three weeks.

Reversal follows. This is a shorter transitional phase in which osteoclasts detach and die, and mononuclear cells clean residual debris from the resorbed cavity while also releasing signaling factors that recruit osteoblast precursors to the site. This phase is comparatively brief and functions as the handoff between the two opposing cell populations, though it received far less research attention historically than resorption and formation, since it leaves no distinct physical marker in the way resorption pits or new bone layers do.

Formation completes the cycle. Osteoblasts, cells derived from mesenchymal stem cells, move into the cleaned cavity and secrete osteoid, an unmineralized collagen-rich matrix, then progressively mineralize it by depositing calcium and phosphate. Formation takes substantially longer than resorption, typically described in the literature as lasting around three months at a given site, which is why bone loss can outpace bone gain relatively quickly if resorption accelerates while formation does not keep pace. Some osteoblasts become permanently embedded in the new matrix they created and differentiate into osteocytes, the long-lived cells that later sense mechanical strain (discussed below); others remain on the bone surface as flattened lining cells, and the remainder undergo programmed cell death once formation is complete.

Individual BMU remodeling cycles, from the start of resorption to the completion of formation at a single site, generally take several months to complete, with resorption lasting roughly two to three weeks and the subsequent formation phase lasting around three months, according to standard descriptions of bone remodeling physiology. Because thousands of these cycles run at staggered, independent sites across the skeleton at any moment, the skeleton as a whole appears to remodel continuously even though no single site remodels quickly.

How do osteoclasts and osteoblasts communicate with each other?

Osteoblasts and marrow stromal cells produce a signaling protein called RANKL (receptor activator of nuclear factor kappa-B ligand), which binds to RANK receptors on osteoclast precursor cells and drives them to mature into active, bone-resorbing osteoclasts. A second protein, osteoprotegerin (OPG), also produced by osteoblasts, acts as a decoy receptor that intercepts RANKL before it can bind RANK, effectively acting as a brake on osteoclast formation. The ratio of RANKL to OPG in the local bone microenvironment is one of the primary determinants of whether resorption or formation dominates at a given site and time.

Osteoblasts vs. osteoclasts: a side-by-side comparison

Although both cell types operate within the same remodeling cycle, they differ in origin, structure, function, and the signals that activate or suppress them.

Feature	Osteoclasts (resorption)	Osteoblasts (formation)
Cell lineage	Hematopoietic (bone marrow monocyte/macrophage lineage)	Mesenchymal stem cell lineage
Structure	Large, multinucleated	Small, mononuclear, cuboidal
Primary action	Dissolve mineral and digest collagen matrix	Secrete collagen matrix (osteoid) and mineralize it
Typical phase duration	~2–3 weeks per site	~3 months per site
Activating signal	RANKL binding to RANK receptor	Mechanical strain, growth factors (e.g., BMPs)
Suppressing signal	Osteoprotegerin (OPG), calcitonin, estrogen	Excess glucocorticoids, aging-related signaling decline
Fate after task	Programmed cell death (apoptosis)	Become osteocytes, lining cells, or undergo apoptosis

Osteoclasts and osteoblasts are lineage-distinct, opposing cell types whose relative activity, not their mere presence, determines whether a given remodeling site gains, loses, or maintains bone mass.

Why bone remodels in response to mechanical stress

Embedded within mineralized bone matrix are osteocytes, former osteoblasts that became surrounded by the bone they built and now make up the majority of all bone cells by number. Osteocytes sit in small internal cavities called lacunae, connected to each other and to the bone surface by a dense network of thin channels called canaliculi, through which they extend cellular processes and communicate. This network allows osteocytes to detect mechanical strain from physical loading, walking, running, jumping, or resistance exercise, and to send chemical signals that adjust local remodeling activity in response.

This mechanosensing relationship is described by Wolff's Law, a principle attributed to 19th-century German anatomist Julius Wolff, which holds that bone adapts its internal architecture over time to the mechanical loads placed on it, reinforcing itself along habitual lines of stress and losing density where load is reduced or absent. A useful comparison is a tree trunk exposed to prevailing wind: rather than growing uniformly outward in all directions, the trunk thickens preferentially on the side that experiences the greatest repeated mechanical stress, reinforcing structure exactly where the load demands it and conserving material elsewhere.

The clearest evidence for Wolff's Law-style adaptation comes from situations at both mechanical extremes. NASA-supported research on astronauts during long-duration spaceflight has documented measurable bone density loss, particularly in weight-bearing bones like the hip and spine, because microgravity removes the habitual mechanical loading signal that normally maintains density in those regions (NASA Human Research Program). At the opposite extreme, studies of unilateral-load athletes, such as competitive tennis players, have documented measurably greater bone mineral density in the playing arm compared to the non-dominant arm, a difference attributable to the repeated asymmetric mechanical loading rather than any systemic hormonal difference between the two limbs.

How does exercise translate into a biological signal for bone growth?

Mechanical strain deforms the fluid within the osteocyte canalicular network, and osteocytes interpret that fluid flow as a loading signal. In response, osteocytes reduce their production of sclerostin, a protein that normally suppresses bone formation, which locally shifts the RANKL–OPG balance and the broader signaling environment toward increased osteoblast activity and reduced osteoclast activity at that site.

Why bone density changes across the human lifespan

Bone mass does not remain constant across life; it follows a predictable arc shaped by growth, hormonal status, and the balance point of the remodeling cycle itself.

During childhood and adolescence, bone modeling (the growth-phase process, distinct from adult remodeling) and a formation-favoring version of remodeling combine to increase both the size and the density of bones. Research on skeletal development indicates that peak bone mass, the maximum density and strength a skeleton reaches, is generally achieved by the late teens to mid-twenties, with the exact age varying by skeletal site and by sex, and that the years around this peak represent the single largest determinant of lifetime skeletal reserve (peak bone mass research summarized in PMC-indexed literature on skeletal development). After peak bone mass is reached, remodeling continues, but its purpose shifts from net growth to maintenance: in healthy young adults, resorption and formation are roughly balanced, so total bone mass stays relatively stable for a period before a slow, gradual age-related decline begins in both sexes, typically starting sometime after the third decade of life.

For women specifically, this gradual decline accelerates sharply around menopause, driven by a hormonal mechanism described in the next section. For men, bone loss also occurs with age but generally follows a more gradual trajectory without an equivalent sharp inflection point, reflecting the absence of a comparably abrupt hormonal transition.

Why does bone density decline especially after menopause?

Estrogen normally restrains osteoclast activity, partly by suppressing RANKL production and partly through direct effects on osteoclast lifespan. The sharp drop in circulating estrogen that occurs at menopause removes that restraint, so osteoclast-driven resorption accelerates while the pace of osteoblast-driven formation does not increase to match it. Research on postmenopausal bone loss consistently describes the first five to ten years after menopause as the period of most rapid density decline, after which the rate of loss typically slows, though it continues gradually thereafter.

Bone as the body's calcium reservoir

Bone remodeling is not purely a structural maintenance system: the skeleton also functions as the body's largest reservoir of calcium, storing roughly 99% of total body calcium in mineralized form, and remodeling is the mechanism by which that reserve is accessed. Because stable blood calcium concentration is essential for processes as fundamental as nerve signal transmission, muscle contraction, and blood clotting, the body maintains tight hormonal control over how much calcium the skeleton releases or absorbs at any moment.

Parathyroid hormone (PTH), secreted by the parathyroid glands, is released when blood calcium drops below its normal range. PTH raises blood calcium through three coordinated actions: stimulating osteoclast-driven bone resorption to release stored calcium, increasing calcium reabsorption in the kidneys so less is lost in urine, and promoting the kidney's conversion of vitamin D into its active hormonal form, which in turn increases calcium absorption from the intestine. Calcitonin, produced by parafollicular (C) cells in the thyroid gland, has the broadly opposite role: it is released when blood calcium is too high and works primarily by suppressing osteoclast activity, reducing the rate at which calcium is released from bone into the bloodstream. Together, PTH and calcitonin function as an antagonistic pair, one pulling blood calcium up and the other pushing it down, though PTH is generally considered the more physiologically dominant regulator of the two in day-to-day calcium homeostasis in adult humans.

This calcium-reservoir role explains why conditions unrelated to mechanical bone health can still produce bone remodeling abnormalities. Chronic kidney disease disrupts the kidney's ability to activate vitamin D and to excrete phosphate properly, which distorts the PTH signaling loop and can drive excessive resorption over time, a pattern described clinically as renal osteodystrophy. Vitamin D deficiency similarly impairs intestinal calcium absorption, prompting a compensatory rise in PTH (secondary hyperparathyroidism) that increases resorption in an effort to keep blood calcium within its narrow normal range, even at the cost of skeletal density. In both cases, the skeleton is not failing on its own; it is being drawn down to protect calcium levels elsewhere in the body, which illustrates that bone remodeling operates as an integrated part of whole-body mineral regulation rather than as an isolated structural process.

Common misconceptions about bone remodeling

A frequent assumption is that bone behaves like an inert building material, similar to a steel beam, that is shaped once during growth and then remains structurally fixed for the rest of life. This is not accurate. Adult bone is metabolically active tissue undergoing continuous, lifelong resorption and formation at thousands of independent sites simultaneously, and the physical bone tissue present today is measurably different, at the cellular and molecular level, from what occupied the same location years earlier.

A second misconception is that all bone in the body turns over at the same rate. Bone tissue exists in two structurally distinct forms: trabecular (or cancellous) bone, a porous, lattice-like tissue found in the interior of vertebrae and the ends of long bones, and cortical (or compact) bone, the dense outer shell that makes up most of the shafts of long bones. Trabecular bone has a much larger surface area relative to its volume, which exposes more tissue to remodeling activity and results in a substantially faster turnover rate than cortical bone. This difference is one reason vertebral bone density can change more quickly, in either direction, than density in the shaft of the femur.

A third misconception treats bone density as reflecting a single, uniform value across the entire skeleton, as though one number could describe the whole body. In practice, different skeletal sites remodel at different rates and respond differently to hormonal and mechanical signals, which is why clinical bone density screening (typically via dual-energy X-ray absorptiometry, or DXA) measures specific sites, most commonly the hip and lumbar spine, rather than inferring whole-skeleton status from a single location.

A fourth misconception is that resorption is inherently a negative or damaging process. Resorption is a necessary and physiologically productive step in bone maintenance: it is how the skeleton removes microscopically damaged tissue, clears the way for fresh mineralized bone, and accesses stored calcium during genuine physiological need. Problems arise specifically when resorption chronically outpaces formation over an extended period, not from the existence of resorption itself, which occurs continuously in a healthy skeleton at balanced levels.

The takeaway

Bone remodeling is a continuous, three-phase cycle, resorption by osteoclasts, a brief reversal period, and formation by osteoblasts, coordinated through the RANKL–OPG signaling system and modulated by both mechanical loading, sensed through the osteocyte network described by Wolff's Law, and systemic hormones including estrogen, parathyroid hormone, and calcitonin. Rather than a fixed structural material, bone is an actively maintained tissue that also functions as the body's principal calcium reservoir, tying skeletal turnover directly to whole-body mineral regulation. Understanding remodeling as an ongoing, signal-driven process rather than a static endpoint clarifies why bone density can rise measurably with loading, why it declines gradually with age, and why that decline accelerates sharply around a specific, well-characterized hormonal transition like menopause.

---

Read next:

• How the body stores and releases glucose
• How kidneys balance salt and water
• Why muscles shake during hard exercise
• Why blood types matter for transfusions

FAQ

Q: What are osteoclasts and osteoblasts?

Osteoclasts are large, multinucleated cells derived from the bone marrow monocyte lineage that resorb existing bone by dissolving its mineral component and digesting its collagen matrix. Osteoblasts are cells derived from mesenchymal stem cells that build new bone matrix and mineralize it. The two cell types work in an alternating sequence at localized sites called basic multicellular units, driving the continuous cycle of bone remodeling throughout life.

Q: How long does one bone remodeling cycle take?

At a single microscopic remodeling site, resorption by osteoclasts typically takes roughly two to three weeks, while the subsequent formation phase by osteoblasts takes considerably longer, generally around three months. Because thousands of these cycles run simultaneously at staggered sites across the skeleton, the skeleton as a whole appears to remodel continuously rather than in discrete, synchronized waves.

Q: Why does exercise strengthen bones?

Mechanical loading deforms fluid within the osteocyte network embedded in bone, and osteocytes interpret that fluid movement as a strain signal. In response, they reduce production of sclerostin, a protein that normally suppresses bone formation, shifting local signaling toward increased osteoblast activity, a pattern described by Wolff's Law.

Q: Why do women lose bone density rapidly after menopause?

Estrogen normally suppresses osteoclast activity, partly by restraining RANKL signaling. The sharp drop in estrogen at menopause removes that restraint, so bone resorption accelerates while formation does not increase to match it, producing the most rapid rate of bone density decline typically seen in the first five to ten years after menopause begins.

Q: What is the difference between bone remodeling and bone modeling?

Bone modeling is the process that shapes and enlarges bones during childhood and adolescent growth, adding new bone in some locations without first resorbing old bone in that same location. Bone remodeling is the lifelong process, active in both childhood and adulthood, in which existing bone tissue at a specific site is first resorbed and then replaced with new bone at that same site.

Q: How does the skeleton help regulate blood calcium levels?

Bone stores roughly 99% of the body's total calcium in mineralized form, and parathyroid hormone can stimulate osteoclasts to resorb bone and release that calcium into the bloodstream whenever blood calcium levels drop. Calcitonin works in the opposite direction, suppressing osteoclast activity when blood calcium is too high, making the skeleton an active participant in whole-body mineral regulation rather than a passive structural store.